U.S.–East Africa center to prevent and find HIV-related cancers and speed connection to care
United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers
This program builds a U.S.–East Africa team to improve prevention, earlier detection, and faster linkage to care for people with HIV at risk for cervical cancer and Kaposi’s sarcoma.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11410157 on NIH RePORTER |
What this research studies
This center brings together hospitals and researchers in East Africa and the U.S. to work on virus-related cancers that affect people living with HIV. It will train and support emerging East African investigators and U.S. junior scientists so local teams can lead studies. The work includes setting up better screening and diagnostic approaches and creating systems to get people from diagnosis to treatment more quickly. Research activities and pilot projects will happen at partnering clinics and hospitals in East Africa with technical support from U.S. sites.
Who could benefit from this research
Good fit: Ideal participants are people living with HIV in East Africa—especially women at risk for cervical cancer and patients with or at risk for Kaposi’s sarcoma—seen at clinics partnering with the center.
Not a fit: People who do not have HIV, who live outside the partnering East African regions, or who have non–virus-related cancers are unlikely to directly benefit from this center’s projects.
Why it matters
Potential benefit: If successful, this work could lead to earlier diagnosis, better prevention, and faster treatment for cervical cancer and Kaposi’s sarcoma among people living with HIV in East Africa.
How similar studies have performed: Screening and HPV-based prevention have reduced cervical cancer elsewhere and linkage-to-care programs have helped in other settings, but this combined research-and-training network in East Africa is a newer, region-specific approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Martin, Jeffrey N — University of California, San Francisco
- Study coordinator: Martin, Jeffrey N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.